PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

, /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Sept. 28, 2025, the company approved non-statutory stock options to purchase an aggregate…

STORM Therapeutics Announces First Patient Dosed in Clinical Collaboration to Evaluate STC-15 in Combination with LOQTORZI® and Appointment of Atif Abbas, M.D., as Chief Medical Officer

, /PRNewswire/ –Mindray(SZSE: 300760), de toonaangevende wereldwijde ontwikkelaar van technologieën voor de gezondheidszorg, lanceerde haaroplossing voor patiëntbewaking BeneVision V SeriestijdensEuroanaesthesia 2025in Lissabon. Aangedreven door een…